These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2506549)

  • 1. A neuropharmacological evaluation of enprostil in animals.
    Wallach MB; Roszkowski AP; Michel AD
    Proc West Pharmacol Soc; 1989; 32():123-35. PubMed ID: 2506549
    [No Abstract]   [Full Text] [Related]  

  • 2. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
    Roszkowski AP; Garay GL; Baker S; Schuler M; Carter H
    J Pharmacol Exp Ther; 1986 Nov; 239(2):382-9. PubMed ID: 3095537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General pharmacology of oxepinac.
    Kojima H; Hashizume T; Chiba T; Tanaka M; Kasai Y; Kasahara A
    Arzneimittelforschung; 1978; 28(3):439-45. PubMed ID: 580753
    [No Abstract]   [Full Text] [Related]  

  • 4. Gastrointestinal and uterine effects of enprostil.
    Wong AG; Turke ML; Perry MR; Blissard DD; Faurot G; Hsu S; Ku P; Smith WL
    Proc West Pharmacol Soc; 1989; 32():41-7. PubMed ID: 2506550
    [No Abstract]   [Full Text] [Related]  

  • 5. GR63799X--a novel prostanoid with selectivity for EP3 receptors.
    Bunce KT; Clayton NM; Coleman RA; Collington EW; Finch H; Humphray JM; Humphrey PP; Reeves JJ; Sheldrick RL; Stables R
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():379-82. PubMed ID: 1825574
    [No Abstract]   [Full Text] [Related]  

  • 6. The gastric antisecretory profile of enprostil.
    Wong AG; Turke ML; Perry MR; Blissard DD; Waterbury LD; Smith WL
    Proc West Pharmacol Soc; 1989; 32():49-56. PubMed ID: 2506551
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of enprostil on cardiovascular and respiratory parameters in the dog, and on hematologic parameters in the rat, monkey, and human.
    Johnson LG; Bruno JJ; Allely MC; Eglen RM; Chang K; Yang D; Alps BJ; Rosenkranz RP; Strosberg AM
    Arzneimittelforschung; 1989 Nov; 39(11):1443-8. PubMed ID: 2515862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of amezinium, a novel antihypotensive drug. VI. Effect on central nervous functions.
    Teschendorf HJ; Kretzschmar R; Kreiskott H; Weifenbach H
    Arzneimittelforschung; 1981; 31(9a):1580-8. PubMed ID: 7197973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiapamil, a new calcium antagonist. 2. Further pharmacological characterization and toxicology.
    Eigenmann R; Gerold M; Hefti F; Jovanovic D; Haeusler G
    Arzneimittelforschung; 1981; 31(9):1401-10. PubMed ID: 7197946
    [No Abstract]   [Full Text] [Related]  

  • 10. [Alfa-amino-o-xylene derivatives. Synthesis and effect on the central nervous system].
    Pifferi G; Monguzzi R; Banfi S; Diena A
    Farmaco Sci; 1970 Mar; 25(3):163-76. PubMed ID: 5453293
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of palmitoyl ethanolamide on the central nervous system.
    Krsiak M; Dvorák Z; Rasková H; Masek K
    Act Nerv Super (Praha); 1971; 13(3):208-9. PubMed ID: 5165412
    [No Abstract]   [Full Text] [Related]  

  • 12. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
    Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological studies on alicyclic amines. (II). Central actions of piperidine, pyrrolidine and piperazine.
    Kasé Y; Miyata T; Kamikawa Y; Kataoka M
    Jpn J Pharmacol; 1969 Jun; 19(2):300-14. PubMed ID: 5308835
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological properties of 4(1-methyl-4-piperidylidine)-9,10-dihydro-4H-benzo-[4,5]cyclohepta[1,2]-thiophene hydrogen maleate (pizotifen).
    Dixon AK; Hill RC; Roemer D; Scholtysik G
    Arzneimittelforschung; 1977; 27(10):1968-79. PubMed ID: 411500
    [No Abstract]   [Full Text] [Related]  

  • 15. Stimulation of mucus production and prevention of aspirin induced ulcerogenesis by enprostil in the rat.
    Waterbury LD; Fisher PE; Garay GL; Petty T; Rosenkranz RP
    Proc West Pharmacol Soc; 1988; 31():21-3. PubMed ID: 3145501
    [No Abstract]   [Full Text] [Related]  

  • 16. [Neuropharmacological investigation of serotonin].
    Shibuya T
    Zasshi Tokyo Ika Daigaku; 1969; 27(2):257-67. PubMed ID: 4980366
    [No Abstract]   [Full Text] [Related]  

  • 17. General pharmacology of [2,2-dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3- dihydro-1H-pyrrolizine-5-yl]-acetic acid in experimental animals.
    Algate DR; Augustin J; Atterson PR; Beard DJ; Jobling CM; Laufer S; Munt PL; Tries S
    Arzneimittelforschung; 1995 Feb; 45(2):159-65. PubMed ID: 7710439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the natural and unnatural isomers and degradation products of enprostil on gastric acid secretion and gastrointestinal motility in the rat.
    Rosenkranz RP; Fisher PE; Turke ML; Perry MR; Wong AG; Wren DL; Cooper GF; Smith WL
    Arzneimittelforschung; 1989 Dec; 39(12):1568-71. PubMed ID: 2516443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological properties of aspartame. I. Evaluation of central nervous system effects.
    Potts WJ; Bloss JL; Nutting EF
    J Environ Pathol Toxicol; 1980; 3(5-6):341-53. PubMed ID: 7441089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral enprostil, a synthetic prostaglandin E2, on intestinal brush border membrane lipid composition following abdominal irradiation in the rat.
    Keelan M; Thomson AB; Clandinin MT; Tavernini M; Walker K; Cheeseman CI
    Clin Invest Med; 1989 Dec; 12(6):350-6. PubMed ID: 2515020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.